OMX Stockholm PI
978,67
|
8,18
|
0,84 %
|
Analysen zu OMX Stockholm PI-Werten
03.09.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
02.09.25 | Hennes & Mauritz AB Neutral | UBS AG | |
02.09.25 | Volvo AB Outperform | RBC Capital Markets | |
02.09.25 | ABB Sector Perform | RBC Capital Markets | |
01.09.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
01.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
01.09.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
01.09.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
29.08.25 | ABB Neutral | JP Morgan Chase & Co. | |
27.08.25 | Volvo AB Buy | Jefferies & Company Inc. | |
27.08.25 | AstraZeneca Hold | Deutsche Bank AG | |
25.08.25 | Volvo AB Buy | Jefferies & Company Inc. | |
20.08.25 | Volvo AB Buy | UBS AG | |
19.08.25 | ABB Sector Perform | RBC Capital Markets | |
19.08.25 | Volvo AB Outperform | RBC Capital Markets | |
19.08.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
18.08.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
14.08.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
08.08.25 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
05.08.25 | AstraZeneca Buy | UBS AG | |
04.08.25 | AstraZeneca Outperform | Bernstein Research | |
01.08.25 | AstraZeneca Outperform | Bernstein Research | |
01.08.25 | Hennes & Mauritz AB Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
31.07.25 | ABB Neutral | UBS AG | |
30.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
29.07.25 | AstraZeneca Outperform | Bernstein Research | |
29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
29.07.25 | AstraZeneca Buy | UBS AG | |
29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
29.07.25 | Nokia Buy | Deutsche Bank AG | |
29.07.25 | Nokia Overweight | JP Morgan Chase & Co. | |
28.07.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
28.07.25 | AstraZeneca Outperform | Bernstein Research | |
28.07.25 | Nokia Hold | Jefferies & Company Inc. | |
25.07.25 | Nokia Underweight | Barclays Capital | |
25.07.25 | Nokia Neutral | UBS AG | |
24.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
24.07.25 | Nokia Market-Perform | Bernstein Research | |
24.07.25 | Nokia Overweight | JP Morgan Chase & Co. | |
23.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. |